title: Basket Trials in Oncology: A Trade-Off Between Complexity and Efficiency.
authors.affiliation: Kristen M. Cunanan, Mithat Gonen, Ronglai Shen, David M. Hyman, Gregory J. Riely, Colin B. Begg, and Alexia Iasonos, Memorial Sloan Kettering Cancer Center, New York, NY.
authors.forename: Kristen M
authors.initials: KM
authors.lastname: Cunanan
authors.affiliation: Kristen M. Cunanan, Mithat Gonen, Ronglai Shen, David M. Hyman, Gregory J. Riely, Colin B. Begg, and Alexia Iasonos, Memorial Sloan Kettering Cancer Center, New York, NY.
authors.forename: Mithat
authors.initials: M
authors.lastname: Gonen
authors.affiliation: Kristen M. Cunanan, Mithat Gonen, Ronglai Shen, David M. Hyman, Gregory J. Riely, Colin B. Begg, and Alexia Iasonos, Memorial Sloan Kettering Cancer Center, New York, NY.
authors.forename: Ronglai
authors.initials: R
authors.lastname: Shen
authors.affiliation: Kristen M. Cunanan, Mithat Gonen, Ronglai Shen, David M. Hyman, Gregory J. Riely, Colin B. Begg, and Alexia Iasonos, Memorial Sloan Kettering Cancer Center, New York, NY.
authors.forename: David M
authors.initials: DM
authors.lastname: Hyman
authors.affiliation: Kristen M. Cunanan, Mithat Gonen, Ronglai Shen, David M. Hyman, Gregory J. Riely, Colin B. Begg, and Alexia Iasonos, Memorial Sloan Kettering Cancer Center, New York, NY.
authors.forename: Gregory J
authors.initials: GJ
authors.lastname: Riely
authors.affiliation: Kristen M. Cunanan, Mithat Gonen, Ronglai Shen, David M. Hyman, Gregory J. Riely, Colin B. Begg, and Alexia Iasonos, Memorial Sloan Kettering Cancer Center, New York, NY.
authors.forename: Colin B
authors.initials: CB
authors.lastname: Begg
authors.affiliation: Kristen M. Cunanan, Mithat Gonen, Ronglai Shen, David M. Hyman, Gregory J. Riely, Colin B. Begg, and Alexia Iasonos, Memorial Sloan Kettering Cancer Center, New York, NY.
authors.forename: Alexia
authors.initials: A
authors.lastname: Iasonos
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D017322:Clinical Trials, Phase II as Topic; D016503:Drug Delivery Systems / Q000379:methods; D015507:Drugs, Investigational / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008495:Medical Oncology / Q000379:methods*; D058990:Molecular Targeted Therapy / Q000379:methods*; D012107:Research Design; D012680:Sensitivity and Specificity; D000077484:Vemurafenib / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D015507:Drugs, Investigational; D000077484:Vemurafenib